Call for PhD Application - INSTITUT CANCER ET IMMUNOLOGIE (ICI)

Concours in June 2021 for the recruitment of 2 PhD students in the ICI PhD program within the Doctoral School of Life and Health Sciences (ED62) of Aix-Marseille Université.

ICI is funding 2 full-time PhD students to start in October 2021 for 3 years.

Presentation of the call

The Doctoral Program in Cancer and Immunolgy of Aix-Marseille Université (AMU) offers 2 PhD contracts for a period of 3 years to students who have validated a master's degree in the top third of their class. The contracts are funded by Institut Cancer et Immunologie (ICI).

The section process takes place in three stages:

  1. a call for projects for research teams with receipt of applications by January 31, 2021 at the latest, 8 projects have been selected below.
  2. a call for applications form future PhD students with receipt of applications by May 15, 2021 at the latest. To apply, send your CV and a cover letter directly to the supervisor of your choice (see projects below).
  3. the auditions of the pre-selected candidates will take place in June 2021 (date to be spedified later), 2 candidates/projects will be selected.

 

PhD Project Proposals to be entered in the PhD Concours

Artificial intelligence and mathematical modeling for prediction of clinical response to immunotherapy

PI : Sébastien Benzekry, CRCM, Inria -  sebastien.benzekry@inria.fr

Integrative study of the dialog between pancreatic tumors and their micro- and macro-environment

PI: Alice Carrier, CRCM -  alice.carrier@inserm.fr

Identifying protective signaling cross-talk between dendritic cells and the tumor microenvironment in breast cancer

PI: Marc Dalod, CIML -  dalod@ciml.univ-mrs.fr

Neural regulation of the anti-tumor immune response

PI: Vincent Feuillet, CIML -  feuillet@ciml.univ-mrs.fr

Investigating the role of the immune niche

PI: Géraldine Guash, CRCM -  geraldine.guash-grangeon@inserm.fr

CRISPR/Cas9 screening for the Identification of the tumoral NKp46 ligand

PI: Emilie Narni-Mancinelli, CIML -  narni@ciml.univ-mrs.fr

RUFY3, a novel modulator of multiple myeloma malignancy

PI: Pierre Philippe, CIML -  pierre@ciml.univ-mrs.fr

Regulation of Foxk1 to control T-cell Activation in Cancer

PI: Romain Roncagalli, CIML -  roncagalli@ciml.univ-mrs.fr

Please directly contact the PI for application consideration

Submission deadline: May 15, 2021

Contact information
Keywords
call, application
students, PhD
cancer, immunology, immuno-oncology
international, interdisciplinarity, collaboration
training, research